Evidence map›Paper›PMID 35031321›Full record

ArticleThe Journal of biological chemistry2022

Stepwise assembly of the eukaryotic translation initiation factor 2 complex.

Sven Vanselow, Lea Neumann-Arnold, Franziska Wojciech-Moock, Wolfgang Seufert

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sven VanselowDepartment of Genetics, Regensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany.
Lea Neumann-ArnoldDepartment of Genetics, Regensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany.
Franziska Wojciech-MoockDepartment of Genetics, Regensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany.
Wolfgang SeufertDepartment of Genetics, Regensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany. Electronic address: wolfgang.seufert@ur.de.
University of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The eukaryotic translation initiation factor 2 (eIF2) has key functions in the initiation step of protein synthesis. eIF2 guides the initiator tRNA to the ribosome, participates in scanning of the mRNA molecule, supports selection of the start codon, and modulates the translation of mRNAs in response to stress. eIF2 comprises a heterotrimeric complex whose assembly depends on the ATP-grasp protein Cdc123. Mutations of the eIF2γ subunit that compromise eIF2 complex formation cause severe neurological disease in humans. To this date, however, details about the assembly mechanism, step order, and the individual functions of eIF2 subunits remain unclear. Here, we quantified assembly intermediates and studied the behavior of various binding site mutants in budding yeast. Based on these data, we present a model in which a Cdc123-mediated conformational change in eIF2γ exposes binding sites for eIF2α and eIF2β subunits. Contrary to an earlier hypothesis, we found that the associations of eIF2α and eIF2β with the γ-subunit are independent of each other, but the resulting heterodimers are nonfunctional and fail to bind the guanosine exchange factor eIF2B. In addition, levels of eIF2α influence the rate of eIF2 assembly. By binding to eIF2γ, eIF2α displaces Cdc123 and thereby completes the assembly process. Experiments in human cell culture indicate that the mechanism of eIF2 assembly is conserved between yeast and humans. This study sheds light on an essential step in eukaryotic translation initiation, the dysfunction of which is linked to human disease.

Indexed as

Eukaryotic Initiation Factor-2Prokaryotic Initiation Factor-2Cell Cycle ProteinsEukaryotic Initiation Factor-2BEukaryotic Initiation Factor-5HumansRNA, Transfer, MetSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCdc123 protein, S cerevisiaeCell Cycle ProteinsEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-2BEukaryotic Initiation Factor-5Prokaryotic Initiation Factor-2RNA, Transfer, MetSaccharomyces cerevisiae ProteinsCdc123cell proliferationeukaryotic initiation factor 2human eIF2molecular chaperoneprotein assemblyprotein complexprotein–protein interactiontranslation initiation factoryeast

Identifiers

PMID35031321
PMCPMC8844851
OpenAlexW4205434514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.